Amgen Inc ESMO Call Transcript
Hello. My name is Sarah, and I will be your conference facilitator today for Amgen's conference call following the 2023 European Society for Medical Oncology Congress. (Operator Instructions) I would now like to introduce Mr. David Reese, Executive Vice President of Research and Development. Mr. Reese, you may now begin.
Thanks, Sarah, and good morning and good afternoon, everyone, depending on where you're joining us from. We're very happy today to give an update on our oncology pipeline after the ESMO meeting, where we had some major data presentations. We have a lot of materials, so we're going to jump right in, in just a moment.
I would note that all of the slides that we're presenting today will be posted on our website immediately following the call.
On the next slide, is our standard safe harbor statement. And if we move to the next slide, you'll see the agenda today. I'll give an introduction to our strategy. Just as a reminder, very briefly, I do want to say a few words
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
